Skip to main content
  • LANDMARK Trial: Myval Noninferior to Contemporary THVs in Treating Native Aortic Stenosis

    The novel balloon-expandable Myval transcatheter heart valve (THV) demonstrated noninferiority to contemporary THVs in patients with severe native aortic stenosis, new randomized trial results show.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details